Bio-Rad Laboratories (NYSE:BIO) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Bio-Rad Laboratories (BIO) operate in?

Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.

Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.

Open	$335.63
Close	$341.75
Volume / Avg.	132.67K / 185.13K
Day Range	$335.42 - $344.37
52 Wk Range	262.12 - 387.99
Market Cap	$9.75B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	42
Short Interest	-
Days to Cover	3.26

Recent News

S&P 500 Shake-Up: New Entrants Driving Market Momentum

The S&P 500 is a widely recognized benchmark for the US stock market, and it has undergone reshuffling due to the quarterly rebalancing process. This shake-up, driven by shifts in company performance and market capitalization, provides a unique lens into the evolving dynamics of the business world. The inclusion of several companies reflects a changing market terrain.

MarketBeat

S&P 500 Shake-Up: New Entrants Driving Market Momentum

MarketBeat

Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF?

Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Invesco S&P 500 Equal Weight Health Care ETF (ARCA:RSPH) is a passively managed exchange traded fund launched on 11/01/2006.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Oct 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$335.63
Close	$341.75
Volume / Avg.	132.67K / 185.13K
Day Range	$335.42 - $344.37
52 Wk Range	262.12 - 387.99
Market Cap	$9.75B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	42
Short Interest	-
Days to Cover	3.26

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Bio-Rad Laboratories (BIO) stock?

You can purchase shares of Bio-Rad Laboratories (NYSE:BIO) through any online brokerage.

View our list of the best stock brokerages

Who are Bio-Rad Laboratories (BIO) competitors?

Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), 10x Genomics (NASDAQ:TXG), Waters (NYSE:WAT), Sotera Health (NASDAQ:SHC) and Quanterix (NASDAQ:QTRX).

What is the forecast, or price target, for Bio-Rad Laboratories (BIO) stock?

Bio-Rad Laboratories has a consensus price target of $435.14.

What is the current price for Bio-Rad Laboratories (BIO)?

The stock price for Bio-Rad Laboratories (NYSE: BIO) is $341.75 last updated January 10, 2025 at 4:00 PM EST.

Does Bio-Rad Laboratories (BIO) pay a dividend?

A quarterly cash dividend of 0.00 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on Invalid DateTime.

When is Bio-Rad Laboratories (NYSE:BIO) reporting earnings?

Bio-Rad Laboratories’s Q4 earnings are confirmed for Thursday, February 13, 2025.

Is Bio-Rad Laboratories (BIO) going to split?

There is no upcoming split for Bio-Rad Laboratories.

What sector and industry does Bio-Rad Laboratories (BIO) operate in?

Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.

Comments

Bio-Rad Laboratories

Bio-Rad Laboratories (BIO) Forecast